AT Bancorp decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.2% during the third quarter, Holdings Channel reports. The institutional investor owned 16,671 shares of the company’s stock after selling 199 shares during the period. AT Bancorp’s holdings in Thermo Fisher Scientific were worth $2,651,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. Moors & Cabot Inc. boosted its position in Thermo Fisher Scientific by 0.4% in the second quarter. Moors & Cabot Inc. now owns 1,994 shares of the company’s stock valued at $294,000 after buying an additional 7 shares in the last quarter. Brown Advisory Securities LLC raised its stake in Thermo Fisher Scientific by 0.4% in the second quarter. Brown Advisory Securities LLC now owns 2,388 shares of the company’s stock valued at $353,000 after buying an additional 10 shares in the last quarter. Mycio Wealth Partners LLC raised its stake in Thermo Fisher Scientific by 1.6% in the second quarter. Mycio Wealth Partners LLC now owns 711 shares of the company’s stock valued at $105,000 after buying an additional 11 shares in the last quarter. SSI Investment Management Inc. raised its stake in Thermo Fisher Scientific by 1.2% in the second quarter. SSI Investment Management Inc. now owns 1,879 shares of the company’s stock valued at $276,000 after buying an additional 23 shares in the last quarter. Finally, Smithfield Trust Co. raised its stake in Thermo Fisher Scientific by 0.5% in the second quarter. Smithfield Trust Co. now owns 5,658 shares of the company’s stock valued at $836,000 after buying an additional 29 shares in the last quarter. Institutional investors own 86.28% of the company’s stock.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) traded up 0.68% on Tuesday, hitting $141.27. 2,576,593 shares of the company traded hands. The firm has a market capitalization of $55.81 billion, a P/E ratio of 28.24 and a beta of 1.24. The firm’s 50-day moving average is $149.29 and its 200 day moving average is $151.92. Thermo Fisher Scientific Inc. has a 1-year low of $119.75 and a 1-year high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.97 by $0.06. Thermo Fisher Scientific had a net margin of 11.10% and a return on equity of 14.95%. The business had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.39 billion. During the same quarter in the previous year, the business posted $1.80 earnings per share. The business’s revenue was up 8.9% compared to the same quarter last year. On average, analysts anticipate that Thermo Fisher Scientific Inc. will post $8.25 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, January 16th. Stockholders of record on Thursday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date of this dividend is Tuesday, December 13th. Thermo Fisher Scientific’s dividend payout ratio is currently 12.00%.

COPYRIGHT VIOLATION NOTICE: “AT Bancorp Cuts Stake in Thermo Fisher Scientific Inc. (TMO)” was originally reported by Daily Political and is the propert of of Daily Political. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this article can be read at http://www.dailypolitical.com/2016/11/29/at-bancorp-cuts-stake-in-thermo-fisher-scientific-inc-tmo.html.

A number of analysts have weighed in on TMO shares. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $178.00 target price on the stock in a research report on Monday, August 1st. Leerink Swann reissued a “buy” rating and set a $175.00 target price on shares of Thermo Fisher Scientific in a research note on Sunday, November 20th. Cleveland Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Friday, September 9th. Bank of America Corp. set a $180.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Friday, October 7th. Finally, JPMorgan Chase & Co. assumed coverage on shares of Thermo Fisher Scientific in a research note on Thursday, September 22nd. They set an “overweight” rating and a $180.00 target price for the company. Two research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus price target of $164.37.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 30,000 shares of the stock in a transaction dated Thursday, September 1st. The shares were sold at an average price of $151.17, for a total transaction of $4,535,100.00. Following the completion of the sale, the chief executive officer now directly owns 308,647 shares of the company’s stock, valued at $46,658,166.99. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Marc N. Casper sold 28,797 shares of the stock in a transaction dated Friday, September 2nd. The shares were sold at an average price of $151.01, for a total transaction of $4,348,634.97. Following the sale, the chief executive officer now directly owns 307,444 shares of the company’s stock, valued at $46,427,118.44. The disclosure for this sale can be found here. Insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.